Tech Company Financing Transactions
Beren Therapeutics Funding Round
Beren Therapeutics, based in Thousand Oaks, scored $300 million in funding from Eisai, Founders Fund and Hercules Capital.
Transaction Overview
Company Name
Announced On
6/10/2026
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$300,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate commercial readiness activities for its lead asset ahead of its upcoming regulatory target date, expand diagnostic integration networks, and build a long-term patient access and family support program.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2101 Corporate Center Dr
Thousand Oaks, CA 91320
USA
Thousand Oaks, CA 91320
USA
Phone
Undisclosed
Website
Email Address
Overview
Beren is public benefit corporation building a new model of integrated, patient-aligned biotechnology. Beren was designed from inception to understand the needs of patient communities, healthcare providers, and health systems in order to identify, develop, and provide access to transformative medicines.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 6/10/2026: Alta Ares venture capital transaction
Next: 6/10/2026: Uncovr venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








